http://orcid.org/0000-0002-0529-9481
Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli & Francesco Tovoli. (2022) Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert Review of Anticancer Therapy 22:4, pages 371-381.
Read now
Read now
Miaoxia Liu, Ruihong Wu, Xu Liu, Hongqin Xu, Xiumei Chi, Xiaomei Wang, Mengru Zhan, Bao Wang, Fei Peng, Xiuzhu Gao, Ying Shi, Xiaoyu Wen, Yali Ji, Qinglong Jin & Junqi Niu. (2020) Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients. Journal of Hepatocellular Carcinoma 7, pages 219-232.
Read now
Read now
Articles from other publishers (28)
Antonella Farina, Sara Tartaglione, Adele Preziosi, Patrizia Mancini, Antonio Angeloni & Emanuela Anastasi. (2024) PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC. International Journal of Molecular Sciences 25:6, pages 3498.
Crossref
Crossref
Wei Teng, Hung-Wei Wang & Shi-Ming Lin. (2024) Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. Liver Cancer, pages 1-19.
Crossref
Crossref
Ding XIONG, Kui ZHANG & Mingqing XU. (2023) Prognostic factors of nivolumab in advanced hepatocellular carcinoma: a systematic review and meta-analysis. Panminerva Medica 65:4.
Crossref
Crossref
Kepu Zheng, Leiyang Dai, Yingpeng Zhao, Laibang Li, Wang Li, Xibing Zhang, Qiuming Su, Ruichao Wu, Yizhou Jiang, Yonglin Chen & Jianghua Ran. (2023) Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population. BMC Gastroenterology 23:1.
Crossref
Crossref
Xiaoming Gong, Tao Chen, Cheyu Lin, Haiqin Ping, Xin Tong, Kai Zhang, Zhaojun Chen, Caiyun Cai, Zhiyan Lu & Hengning Ke. (2023) Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening. BioMed Research International 2023, pages 1-13.
Crossref
Crossref
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee & Henry Lik Yuen Chan. (2023) Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clinical and Molecular Hepatology 29:2, pages 277-292.
Crossref
Crossref
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan & Alexandra Crăciun. (2023) Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics 13:5, pages 816.
Crossref
Crossref
Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, Patrizia Carucci, Emanuela Rolle, Alessandra Risso, Michela Emma Burlone, Alice Albè, Martina Crevola, Emma Clara Musso, Chiara Rosso, Angelo Armandi, Antonella Olivero, Rosalba Minisini, Giorgio Maria Saracco, Elisabetta Bugianesi, Mario Pirisi, Alessia Ciancio & Silvia Gaia. (2023) Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development. Biology 12:1, pages 94.
Crossref
Crossref
Takako Inoue & Yasuhito Tanaka. 2023. Comprehensive Guide to Hepatitis Advances. Comprehensive Guide to Hepatitis Advances
31
60
.
Guojun Hou, Wenfang Xu, Dongyang Ding, Tao Tian, Gang Liu, Yuan Yang, Hui Liu & Weiping Zhou. (2022) Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 37:12, pages 2321-2330.
Crossref
Crossref
Si-Yu Liu, Chao Li, Li-Yang Sun, Ming-Cheng Guan, Li-Hui Gu, Dong-Xu Yin, Lan-Qing Yao, Lei Liang, Ming-Da Wang, Hao Xing, Hong Zhu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Xiang-Min Tong & Tian Yang. (2022) ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis. Frontiers in Oncology 12.
Crossref
Crossref
Gian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, Patrizia Carucci, Chiara Rosso, Emanuela Rolle, Angelo Armandi, Serena Aneli, Antonella Olivero, Alessandra Risso, Davide Giuseppe Ribaldone, Christian Fermer, Giorgio Maria Saracco, Silvia Gaia & Elisabetta Bugianesi. (2022) Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease. Current Oncology 29:8, pages 5457-5465.
Crossref
Crossref
Aurora NICOLOSI & Gian P. CAVIGLIA. (2022) The evolution in the search for biomarkers of liver diseases. Gazzetta Medica Italiana Archivio per le Scienze Mediche 180:10.
Crossref
Crossref
Honglei Feng, Bole Li, Ze Li, Qian Wei & Li Ren. (2021) PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 21:1.
Crossref
Crossref
Stuart K. Roberts, Ammar Majeed & William Kemp. (2021) Controversies in the Management of Hepatitis B. Clinics in Liver Disease 25:4, pages 785-803.
Crossref
Crossref
Gian Paolo Caviglia, Angelo Armandi, Chiara Rosso, Silvia Gaia, Serena Aneli, Emanuela Rolle, Maria Lorena Abate, Antonella Olivero, Aurora Nicolosi, Marta Guariglia, Davide Giuseppe Ribaldone, Patrizia Carucci, Giorgio Maria Saracco & Elisabetta Bugianesi. (2021) Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Cancers 13:10, pages 2305.
Crossref
Crossref
Carolina MARTELLETTI, Angelo ARMANDI, Gian Paolo CAVIGLIA, Giorgio M. SARACCO & Rinaldo PELLICANO. (2021) Elastography for characterization of focal liver lesions: current evidence and future perspectives. Minerva Gastroenterology 67:2.
Crossref
Crossref
Fei Xu, Lulu Zhang, Wenting He, Di Song, Xiaomeng Ji & Jianyong Shao. (2021) The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients. Disease Markers 2021, pages 1-9.
Crossref
Crossref
Nergis Ekmen, Çağri Akalin & Murat Akyildiz. (2020) Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates. European Journal of Gastroenterology & Hepatology 32:2, pages 294-299.
Crossref
Crossref
Gian Paolo Caviglia, Michela Ciruolo, Maria Lorena Abate, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Antonella Olivero, Giulia Troshina, Alessandra Risso, Aurora Nicolosi, Davide Giuseppe Ribaldone, Angelo Armandi, Francesco Tandoi, Giorgio Maria Saracco, Elisabetta Bugianesi, Alessia Ciancio & Silvia Gaia. (2020) Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology. Cancers 12:11, pages 3218.
Crossref
Crossref
Jia Fan, Yu Chen, Dan Zhang, Juan Yao, Zijun Zhao, Yao Jiang, Yiqin Li & Yongcan Guo. (2020) Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis. Surgical Oncology 34, pages 245-255.
Crossref
Crossref
Weiyi Wang & Chao Wei. (2020) Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases 7:3, pages 308-319.
Crossref
Crossref
Fei Xu, Lulu Zhang, Yuxia Xu, Di Song, Wenting He, Xiaomeng Ji & Jianyong Shao. (2020) Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma. Cancers 12:8, pages 2332.
Crossref
Crossref
Takako Inoue & Yasuhito Tanaka. (2020) Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 26:3, pages 261-279.
Crossref
Crossref
Ruifeng Xun, Hougen Lu & Xianwang Wang. (2020) Identification of CDC25C as a Potential Biomarker in Hepatocellular Carcinoma Using Bioinformatics Analysis. Technology in Cancer Research & Treatment 19, pages 153303382096747.
Crossref
Crossref
Katell Peoc'h, Hana Manceau, Zoubida Karim, Staffan Wahlin, Laurent Gouya, Hervé Puy & Jean-Charles Deybach. (2019) Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword. Molecular Genetics and Metabolism 128:3, pages 236-241.
Crossref
Crossref
Teresa Granato, Emanuela Anastasi, Antonio Angeloni, Cinzia Marchese, Lucia Manganaro, Valentina Viggiani, Serena Rita Zarrillo, Irene Pecorella & Sara Tartaglione. (2019) Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study. Biochemia medica 29:2, pages 352-358.
Crossref
Crossref
Daniela Campion, Alessandra Tucci, Paola Ponzo & Gian Paolo Caviglia. (2019) Non-invasive biomarkers for the detection of hepatocellular carcinoma. Minerva Biotecnologica 31:1.
Crossref
Crossref